SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-014811
Filing Date
2020-08-06
Accepted
2020-08-06 08:00:32
Documents
59
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 449037
2 ex10-1.htm EX-10.1 170328
3 ex31-1.htm EX-31.1 11529
4 ex31-2.htm EX-31.2 11336
5 ex32-1.htm EX-32.1 9965
  Complete submission text file 0001493152-20-014811.txt   3240787

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE cocp-20200630.xml EX-101.INS 440773
7 XBRL SCHEMA FILE cocp-20200630.xsd EX-101.SCH 47027
8 XBRL CALCULATION FILE cocp-20200630_cal.xml EX-101.CAL 51741
9 XBRL DEFINITION FILE cocp-20200630_def.xml EX-101.DEF 156417
10 XBRL LABEL FILE cocp-20200630_lab.xml EX-101.LAB 320556
11 XBRL PRESENTATION FILE cocp-20200630_pre.xml EX-101.PRE 233458
Mailing Address 19805 N. CREEK PARKWAY BOTHELL WA 98011
Business Address 19805 N. CREEK PARKWAY BOTHELL WA 98011 (786) 459-1831
Cocrystal Pharma, Inc. (Filer) CIK: 0001412486 (see all company filings)

IRS No.: 352528215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38418 | Film No.: 201079905
SIC: 2834 Pharmaceutical Preparations